Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cytek Biosciences (CTKB) Leases (2022 - 2025)

Cytek Biosciences (CTKB) has disclosed Leases for 4 consecutive years, with $11.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases rose 11.28% year-over-year to $11.3 million, compared with a TTM value of $11.3 million through Dec 2025, up 11.28%, and an annual FY2025 reading of $11.3 million, up 11.28% over the prior year.
  • Leases was $11.3 million for Q4 2025 at Cytek Biosciences, up from $11.2 million in the prior quarter.
  • Across five years, Leases topped out at $16.4 million in Q2 2025 and bottomed at $9.3 million in Q2 2024.
  • Average Leases over 4 years is $12.0 million, with a median of $11.5 million recorded in 2023.
  • The sharpest move saw Leases dropped 24.91% in 2024, then surged 75.68% in 2025.
  • Year by year, Leases stood at $13.9 million in 2022, then dropped by 21.83% to $10.9 million in 2023, then fell by 6.31% to $10.2 million in 2024, then increased by 11.28% to $11.3 million in 2025.
  • Business Quant data shows Leases for CTKB at $11.3 million in Q4 2025, $11.2 million in Q3 2025, and $16.4 million in Q2 2025.